INMD Inmode Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: INMD

Price (delayed)

$13.65

Market cap

$865.42M

P/E Ratio

9.89

Dividend/share

N/A

EPS

$1.38

Enterprise value

$475.96M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 76

inmode offers the most exciting and effective aesthetic solutions with fractora, forma/plus, lumeccca, diolaze and bodyfx. fractora: bipolar radio-frequency fractional treatment for superior improvements in texture, wrinkles, acne scars and ...

Highlights
The company's debt fell by 14% YoY and by 3.6% QoQ
The price to earnings (P/E) is 34% less than the 5-year quarterly average of 14.9 but 19% more than the last 4 quarters average of 8.2
Inmode's equity has increased by 7% YoY but it has decreased by 3.2% QoQ
INMD's net income has dropped by 50% year-on-year and by 7% since the previous quarter
The EPS is down by 41% year-on-year and by 4.8% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://inmodemd.com
Peers: OBIO OM

Key stats

What are the main financial stats of INMD

INMD stock price

How has the Inmode stock price performed over time
Intraday
1.19%
1 week
-2.85%
1 month
-4.61%
1 year
-7.33%
YTD
-7.08%
QTD
-0.22%

Financial performance

How have Inmode's revenue and profit performed over time
Revenue
$374.64M
Gross profit
$291.61M
Operating income
$79.83M
Net income
$87.19M
Gross margin
77.8%
Net margin
23.3%
INMD's net income has dropped by 50% year-on-year and by 7% since the previous quarter
The company's net margin fell by 48% YoY and by 8% QoQ
Inmode's operating income has decreased by 27% YoY and by 7% QoQ
Inmode's operating margin has decreased by 24% YoY and by 7% from the previous quarter

Price vs fundamentals

How does INMD's price correlate with its fundamentals

Growth

What is Inmode's growth rate over time

Valuation

What is Inmode stock price valuation
INMD P/E details
P/E
9.89
P/B
1.31
P/S
2.31
EV/EBIT
4.66
EV/EBITDA
4.63
EV/Sales
1.27
The EPS is down by 41% year-on-year and by 4.8% since the previous quarter
The price to earnings (P/E) is 34% less than the 5-year quarterly average of 14.9 but 19% more than the last 4 quarters average of 8.2
INMD's P/B is 73% below its 5-year quarterly average of 4.7 and 8% below its last 4 quarters average of 1.4
Inmode's equity has increased by 7% YoY but it has decreased by 3.2% QoQ
INMD's price to sales (P/S) is 63% lower than its 5-year quarterly average of 6.1 and 5% lower than its last 4 quarters average of 2.4
INMD's revenue is down by 4.5% year-on-year

Efficiency

How efficient is Inmode business performance
Inmode's ROA has decreased by 47% YoY and by 9% from the previous quarter
INMD's return on equity is down by 47% year-on-year and by 8% since the previous quarter
The ROS is down by 23% year-on-year and by 8% since the previous quarter
The return on invested capital rose by 11% year-on-year and by 6% since the previous quarter

Dividends

What is INMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INMD.

Financial health

How did Inmode financials performed over time
The company's current ratio fell by 11% QoQ
The quick ratio has contracted by 11% from the previous quarter
The company's debt is 99% lower than its equity
The company's debt fell by 14% YoY and by 3.6% QoQ
Inmode's equity has increased by 7% YoY but it has decreased by 3.2% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.